- Home
- DNN vs NMRA Comparison
DNN vs NMRA Comparison
Compare DNN & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- NMRA
- Stock Information
- Founded
- DNN 1936
- NMRA 2019
- Country
- DNN Canada
- NMRA United States
- Employees
- DNN N/A
- NMRA N/A
- Industry
- DNN Other Metals and Minerals
- NMRA
- Sector
- DNN Basic Materials
- NMRA
- Exchange
- DNN Nasdaq
- NMRA Nasdaq
- Market Cap
- DNN 1.3B
- NMRA 121.0M
- IPO Year
- DNN 1997
- NMRA 2023
- Fundamental
- Price
- DNN $1.77
- NMRA $0.80
- Analyst Decision
- DNN Strong Buy
- NMRA Buy
- Analyst Count
- DNN 2
- NMRA 8
- Target Price
- DNN $3.00
- NMRA $9.29
- AVG Volume (30 Days)
- DNN 174.1M
- NMRA 1.4M
- Earning Date
- DNN 08-07-2025
- NMRA 08-05-2025
- Dividend Yield
- DNN N/A
- NMRA N/A
- EPS Growth
- DNN N/A
- NMRA N/A
- EPS
- DNN N/A
- NMRA N/A
- Revenue
- DNN $3,176,679.00
- NMRA N/A
- Revenue This Year
- DNN $288.69
- NMRA N/A
- Revenue Next Year
- DNN $22.40
- NMRA N/A
- P/E Ratio
- DNN N/A
- NMRA N/A
- Revenue Growth
- DNN 24.45
- NMRA N/A
- 52 Week Low
- DNN $1.08
- NMRA $0.61
- 52 Week High
- DNN $2.47
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- DNN 57.31
- NMRA 44.07
- Support Level
- DNN $1.72
- NMRA $0.72
- Resistance Level
- DNN $1.88
- NMRA $0.85
- Average True Range (ATR)
- DNN 0.10
- NMRA 0.07
- MACD
- DNN -0.00
- NMRA -0.02
- Stochastic Oscillator
- DNN 69.70
- NMRA 8.08
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.